Biorigin's $46 million expansion plan
Biorigin, dedicated to the development of innovative solutions from yeasts
and derivatives, has announced the investment of US$46 million until the end of
2008 in its Operations and R&D units.
Biorgin's objective is to increase production capacity from 18,000 tonnes per
year to 35,000 tpy at the end of 2008. The $40-million investment in the
productive unit is expected to double the fermentation, autolysis and also the
drying processes, thus contributing to the removal of some productive
The first phase of investments will be initiated in R&D
unit that aims at the twofold increase of the already existing area. Approx. $6
million will be invested in the construction of two new buildings for the
One of the new buildings will be
focused on fermentation to improve already existing processes, as well as to
develop new processes contributing the work of constant search for ingredients
with high added value.
The other building will hold the microbiology
area and will be dedicated to the study and discovery of micro-organisms aiming
at defined functionalities or in the search for new applications.
entire investment project in the R&D area of Biorigin deals with the
construction of eight new buildings similar in size and with different
To comment, login here
Or register to be able to comment.